Drew Sycoff Purchases 182,540 Shares of GlucoTrack, Inc. (NASDAQ:GCTK) Stock

GlucoTrack, Inc. (NASDAQ:GCTK) Director Drew Sycoff bought 182,540 shares of the business’s stock in a transaction dated Monday, April 22nd. The shares were bought at an average cost of $1.26 per share, for a total transaction of $230,000.40. Following the purchase, the director now directly owns 2,951,258 shares in the company, valued at approximately $3,718,585.08. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

GlucoTrack Trading Down 4.0 %

Shares of GCTK opened at $0.46 on Friday. The firm’s 50-day moving average price is $0.38 and its 200-day moving average price is $0.28. The firm has a market capitalization of $12.31 million, a price-to-earnings ratio of -1.24 and a beta of 0.29. The company has a current ratio of 3.22, a quick ratio of 3.22 and a debt-to-equity ratio of 0.06. GlucoTrack, Inc. has a 1-year low of $0.13 and a 1-year high of $0.99.

GlucoTrack (NASDAQ:GCTK) last announced its earnings results on Thursday, March 28th. The company reported ($0.10) earnings per share for the quarter.

About GlucoTrack

GlucoTrack, Inc, a medical device company, focuses on designing, developing, and commercializing non-invasive glucose monitoring devices for use by people with diabetes in the United States. It develops GlucoTrack, a non-invasive blood glucose monitor that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.